Cite
HARVARD Citation
Dellon, E. et al. (n.d.). A Randomized, Double‐Blind, Placebo‐Controlled Trial of a Novel Recombinant, Humanized, Anti‐Interleukin‐13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study. American journal of gastroenterology. p. . [Online].